Preparation parameters effect of on PDI of self-assembled chitosan/streptokinase NPs

Publish Year: 1393
نوع سند: مقاله کنفرانسی
زبان: English
View: 708

متن کامل این Paper منتشر نشده است و فقط به صورت چکیده یا چکیده مبسوط در پایگاه موجود می باشد.
توضیح: معمولا کلیه مقالاتی که کمتر از ۵ صفحه باشند در پایگاه سیویلیکا اصل Paper (فول تکست) محسوب نمی شوند و فقط کاربران عضو بدون کسر اعتبار می توانند فایل آنها را دریافت نمایند.

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

ICNN05_728

تاریخ نمایه سازی: 30 آبان 1394

Abstract:

Self-assembly method used to prepare streptokinase (Spa) and chitosan (Cs) nanoparticles (NPs).Concentration of Cs, pH of solution and stirring time as independent variables were studied to identify their effects onpolydispersity index (PDI) of prepared NPs using Box-Behnken design. Results showed minimum PDI was observed atminimum concentration of Cs and highest values of stirring time. Also to obtain the smallest PDI a specific pH value(~5.6) was necessary. The model predicted that the optimum values are 0.5 mg/ml, 5.18 and 30 min for the Csconcentration, solution pH and stirring time, respectively. The obtained preparation was predicted to have PDI of0.29. By experimentally preparation of NPs in optimum values of Cs concentration, pH and stirring time, NPs had amean PDI of 0.31 (± 0.23). Comparison of the experimental results with predicted values by the model shows a goodagreement between the two data sets, indicating the ability of the model to predict and optimize the data.

Authors

Hadi Baharifar

Department of Medical Nanotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran

Sepideh Arbabi Bidgoli

Toxicogenomics Lab, Faculty of Pharmacy, Pharmaceutical Sciences Branch, Islamic Azad University, Tehran, Iran

Hossein Ghanbari

Department of Medical Nanotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran

Mohammad Ali Faramarzi

Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran